Skip to content
GLP-1 Scorecard
Menu
Site position #237

Zeuss

Published by GLP-1 ScorecardUpdated

Zeuss is a multi-vertical telehealth platform offering compounded semaglutide and tirzepatide for weight loss alongside TRT, HRT, skin, and hair services.

Visit ZeussWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$125/mo (compounded)
Tirzepatide
$175/mo (compounded)
Coverage
Coverage not published
Brand-name
Not confirmed

Weigh Zeuss against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value85/100
Dose & formulation64/100
Clinical oversight55/100
Labs & monitoring52/100
Fulfillment67/100
Contract terms61/100

Strengths

  • One-time-purchase model with no subscription — genuinely rare among DTC GLP-1 providers
  • Publishes the FDA compounded-medication disclaimer
  • Names both 503A and 503B compounding pathways — uncommon transparency
  • Bundled pricing covers provider review, meds, and cold-chain shipping with no hidden fees
  • Full refund if a physician can't prescribe

What to consider

  • 503A pharmacy partner not named (only generic '503A and 503B state-licensed' framing)
  • LegitScript certification not mentioned
  • No named medical director or physician leadership
  • Full states-served list not disclosed
  • FDA issued Zeuss LLC dba Zeuss a warning letter in February 2026; the letter is public in FDA's warning-letter database

Bottom line — Grade C

Best for: Shoppers who want the only one-time-purchase, no-subscription compounded GLP-1 model.

Site position #237 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

FDAWarning letter issued to Zeuss LLC dba Zeuss in February 2026. See the FDA warning-letter database.

Closest here

The rankings grading nearest Zeuss — the realistic shortlist.

The 21 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect Zeuss's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Zeuss's site. Not medical advice; see our disclosure.

← Back to the scorecard